Market Runner: 0.99 is Allscripts Healthcare Solutions Inc’s (NASDAQ:MDRX) Institutional Investor Sentiment

December 1, 2016 - By Adrian Mccoy   ·   0 Comments

Market Runner: 0.99 is Allscripts Healthcare Solutions Inc's (NASDAQ:MDRX) Institutional Investor Sentiment

Sentiment for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) institutional sentiment decreased to 0.99 in 2016 Q2. Its down -0.26, from 1.25 in 2016Q1. The ratio has worsened, as 114 investment managers increased and started new positions, while 91 decreased and sold their stakes in Allscripts Healthcare Solutions Inc. The investment managers in our partner’s database now hold: 185.59 million shares, down from 190.21 million shares in 2016Q1. Also, the number of investment managers holding Allscripts Healthcare Solutions Inc in their top 10 positions was flat from 2 to 2 for the same number . Sold All: 27 Reduced: 64 Increased: 89 New Position: 25.

Allscripts Healthcare Solutions, Inc. delivers information technology and services to help healthcare organizations in clinical, financial and operational results. The company has a market cap of $2.02 billion. The Firm operates through two divisions: Clinical and Financial Solutions, and Population Health. It currently has negative earnings. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services.

About 565,686 shares traded hands. Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has declined 19.09% since April 28, 2016 and is downtrending. It has underperformed by 25.01% the S&P500.

Analysts await Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) to report earnings on February, 16. They expect $0.12 earnings per share, up 9.09% or $0.01 from last year’s $0.11 per share. MDRX’s profit will be $22.32M for 22.63 P/E if the $0.12 EPS becomes a reality. After $0.11 actual earnings per share reported by Allscripts Healthcare Solutions Inc for the previous quarter, Wall Street now forecasts 9.09% EPS growth.

According to Zacks Investment Research, “Allscripts Healthcare Solutions, Inc. offers clinical software, services, information and connectivity solutions that enable physicians and healthcare providers to deliver patients safety and clinical outcomes in the US. The Company provides intuitive clinical and business solutions including Electronic Health Records, practice management, revenue cycle management, document management, electronic prescribing, clinical trials and services for small to mid-sized practices. It also provides advanced clinical and business solutions including Electronic Health Records, practice management, revenue cycle management, document management, electronic prescribing, clinical trials and optimization services for large physician practices, academic medical centers and hospitals. In addition, the Company’s Health Systems Group has Emergency Department and care management systems for hospitals, as well as homecare and referral management solutions for post-acute providers. Allscripts is headquartered in Chicago, Illinois.”

Glenhill Advisors Llc holds 12.6% of its portfolio in Allscripts Healthcare Solutions Inc for 13.73 million shares. Blue Harbour Group L.P. owns 11.26 million shares or 5.92% of their US portfolio. Moreover, Broadview Advisors Llc has 2.09% invested in the company for 1.10 million shares. The New York-based Paradigm Capital Management Inc Ny has invested 1.73% in the stock. Adirondack Research & Management Inc., a New York-based fund reported 361,259 shares.#img1#

Insider Transactions: Since January 1, 0001, the stock had 0 insider purchases, and 7 insider sales for $1.20 million net activity.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) Ratings Coverage

Ratings analysis reveals 56% of Allscripts-Misys Healthcare’s analysts are positive. Out of 16 Wall Street analysts rating Allscripts-Misys Healthcare, 9 give it “Buy”, 0 “Sell” rating, while 7 recommend “Hold”. The lowest target is $13 while the high is $19.0. The stock’s average target of $15.58 is 43.46% above today’s ($10.86) share price. MDRX was included in 26 notes of analysts from August 5, 2015. The firm has “Overweight” rating given on Tuesday, November 17 by JP Morgan. Topeka Capital Markets maintained Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) on Tuesday, January 5 with “Hold” rating. The firm earned “Mkt Perform” rating on Monday, January 4 by Raymond James. The rating was downgraded by Deutsche Bank to “Hold” on Thursday, November 10. RBC Capital Markets maintained Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) rating on Wednesday, August 5. RBC Capital Markets has “Sector Perform” rating and $14 price target. Topeka Capital Markets maintained Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) on Wednesday, August 5 with “Hold” rating. The firm earned “Outperform” rating on Friday, February 19 by RBC Capital Markets. The rating was reinitiated by Jefferies on Friday, October 16 with “Buy”. The firm has “Neutral” rating given on Friday, May 13 by Citigroup. The firm earned “Outperform” rating on Tuesday, August 23 by Leerink Swann.

MDRX Company Profile

Allscripts Healthcare Solutions, Inc., incorporated on July 11, 2000, delivers information technology (IT) and services to help healthcare organizations in clinical, financial and operational results. The Firm operates through two divisions: Clinical and Financial Solutions, and Population Health. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services. The Company’s Population Health segment includes the sale of health management and coordinated care solutions, which are mainly focused on hospitals, health systems, other care facilities and accountable care organizations (ACOs). These solutions enable clients to connect, transition, analyze, and coordinate care across the care community.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Adrian Mccoy


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>